Apteka Osaksp. j.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-07-30
Registered address
Armii Krajowej 31, 19-300 Ełk, Poland
Electronic delivery address
AE:PL-54263-35735-GAUSR-26

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 14 days early.

  • 202514/07/2026
  • 202411/07/2025
  • 202312/07/2024
  • 202207/07/2023
  • 202109/05/2022
  • 202015/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 2.70mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 127.55kMedianUSD 20.66kAverageUSD 86.55k
Operating costs
This companyUSD 2.56mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 547.29kMedianUSD 544.32kAverageUSD 1.76m

National Health Fund (NFZ) contracts

Apteka Osak has been an NFZ healthcare provider since 2008. In 2026 it is performing 1 contract worth USD 0.00. All its contracts were worth USD 0.00 in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Provision of medical deviceswarmińsko-mazurskie1USD 0.00

Ownership

Owner
Michał Osakage 56
Stanisława Osakage 86
Tomasz Adam Osakage 50
Ewa Osak Cooperage 62

Manner of representation

Each partner is entitled to independently conduct the affairs of the company and represent it.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 1993-07-05.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Buildings and premises
PLN 20,226

Public aid

6 public aid cases recorded, with a total value of $86,919.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$198
De minimis aid (in accordance with Commission Regulation 2023/2831)
$614
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$3,752

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Adpharmasp. z o.o.
Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j.
Novopharm - Millersp. j.
Pikadasp. z o.o.
Vitasp. z o.o.
Gold Lionsp. z o.o.
Grupa Aptekarska Kujałowiczsp. j.
Herbarium Świętego Franciszkasp. z o.o.
Eurekasp. z o.o.
Pharmer Polskasp. z o.o.

FAQ

Last updated: 2026-07-15